Total Payments
$4,361
2024 Payments
$1,419
Companies
30
Transactions
127
Medicare Patients
9,919
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$4,336 (99.4%)
Other$25.59 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,336 | 126 | 99.4% |
| Honoraria | $25.59 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $540.80 | 26 | $0 (2024) |
| Alcon Vision LLC | $481.42 | 9 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $455.71 | 9 | $0 (2024) |
| Dompe US, Inc. | $417.22 | 9 | $0 (2024) |
| Allergan, Inc. | $388.02 | 19 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $313.12 | 8 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $306.53 | 10 | $0 (2024) |
| Johnson & Johnson Vision Care, Inc. | $250.00 | 2 | $0 (2024) |
| Amgen Inc. | $159.45 | 3 | $0 (2024) |
| Horizon Therapeutics plc | $143.62 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,419 | 35 | BIOTISSUE HOLDINGS INC. ($306.53) |
| 2023 | $785.61 | 24 | Bausch & Lomb Americas Inc. ($267.85) |
| 2022 | $987.16 | 36 | Dompe US, Inc. ($267.92) |
| 2021 | $732.38 | 26 | Allergan, Inc. ($223.56) |
| 2020 | $28.73 | 1 | Glaukos Corporation ($28.73) |
| 2019 | $408.26 | 5 | Alcon Vision LLC ($392.19) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 12/02/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $42.85 | General |
| 11/26/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $44.99 | General |
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| 11/20/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $43.50 | General |
| 11/14/2024 | Harrow Eye, LLC | ILEVRO (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: OPTOMETRY | ||||||
| 11/08/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $21.00 | General |
| 10/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 10/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $44.99 | General |
| 10/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $121.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/19/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $36.18 | General |
| Category: Corneal Health | ||||||
| 09/10/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Ophthalmology | ||||||
| 09/05/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: OPTOMETRY | ||||||
| 08/29/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $99.93 | General |
| Category: Ophthalmology | ||||||
| 08/02/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: SOLUTION/ DROPS | ||||||
| 06/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: EYE CARE | ||||||
| 06/10/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $23.20 | General |
| 06/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Ophthalmology | ||||||
| 06/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: SOLUTION/ DROPS | ||||||
| 05/13/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,673 | 3,428 | $1.5M | $421,788 |
| 2022 | 21 | 2,953 | 3,630 | $1.2M | $379,120 |
| 2021 | 21 | 3,073 | 3,525 | $902,383 | $322,080 |
| 2020 | 18 | 1,220 | 1,321 | $265,624 | $103,050 |
Total Patients
9,919
Total Services
11,904
Medicare Billing
$1.2M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 199 | 365 | $709,925 | $150,673 | 21.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 309 | 445 | $325,580 | $107,561 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 575 | 655 | $98,250 | $59,475 | 60.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 249 | 339 | $37,290 | $23,070 | 61.9% |
| 92134 | Imaging of retina | Office | 2023 | 537 | 562 | $70,250 | $16,055 | 22.9% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 19 | 26 | $55,900 | $15,536 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 110 | 110 | $23,980 | $11,847 | 49.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 215 | 352 | $52,800 | $10,348 | 19.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 72 | 73 | $14,600 | $6,299 | 43.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 88 | 123 | $15,375 | $5,662 | 36.8% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 24 | 34 | $17,600 | $5,539 | 31.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 80 | 108 | $13,500 | $2,692 | 19.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 22 | 22 | $4,620 | $2,341 | 50.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $1,833 | $1,083 | 59.1% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 26 | 33 | $5,610 | $1,016 | 18.1% |
| 92025 | Ct scan of cornea | Office | 2023 | 32 | 35 | $4,350 | $944.13 | 21.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 77 | 107 | $3,745 | $902.49 | 24.1% |
| 92250 | Photography of the retina | Office | 2023 | 26 | 26 | $3,380 | $744.86 | 22.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 322 | 459 | $336,530 | $111,969 | 33.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 123 | 203 | $394,835 | $85,612 | 21.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 711 | 870 | $130,500 | $79,090 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 223 | 275 | $30,250 | $17,608 | 58.2% |
| 92134 | Imaging of retina | Office | 2022 | 537 | 565 | $70,625 | $16,698 | 23.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 199 | 261 | $32,625 | $11,692 | 35.8% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 13 | 17 | $36,550 | $10,014 | 27.4% |
About Dr. Maxwell Burch, MD
Dr. Maxwell Burch, MD is a Ophthalmology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1174919583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maxwell Burch, MD has received a total of $4,361 in payments from pharmaceutical and medical device companies, with $1,419 received in 2024. These payments were reported across 127 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,336).
As a Medicare-enrolled provider, Burch has provided services to 9,919 Medicare beneficiaries, totaling 11,904 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Fort Myers, FL
- Active Since 04/13/2015
- Last Updated 06/11/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174919583
Products in Payments
- DURYSTA (Drug) $926.69
- Cequa (Drug) $455.71
- OXERVATE (Drug) $417.22
- ReSTOR (Device) $286.16
- Acuvue (Device) $250.00
- TEPEZZA (Biological) $159.45
- TEPEZZA (Drug) $143.62
- XIIDRA (Drug) $126.70
- XDEMVY (Drug) $124.97
- INFUSE (Device) $122.64
- DEXTENZA (Drug) $109.43
- MIEBO (Drug) $106.94
- Centurion (Device) $106.03
- MyDay Contact Lens (Device) $102.68
- rhopressa (Drug) $52.32
- VYZULTA (Drug) $44.04
- Clareon (Device) $37.53
- CE-marked KXLA system (Device) $36.18
- TECNIS IOL (Device) $32.10
- OMNI(R) SURGICAL SYSTEM (US) (Device) $31.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Fort Myers
Duane Wiggins, M.d, M.D
Ophthalmology — Payments: $271,261
Ophthalmology $271,261
Dr. Stephen Smith, M.d, M.D
Ophthalmology — Payments: $51,062
Ophthalmology $51,062
Dr. Alexander Eaton, Md, MD
Ophthalmology — Payments: $45,038
Ophthalmology $45,038
Jeffrey Robin, M.d, M.D
Ophthalmology — Payments: $17,017
Ophthalmology $17,017
Dr. Michael Collins, M.d, M.D
Ophthalmology — Payments: $16,447
Ophthalmology $16,447
Dr. Ashish Sharma, Md, MD
Ophthalmology — Payments: $12,394
Ophthalmology $12,394